Literature DB >> 6978807

Lymphopenia and abnormal lymphocyte subsets in the "BB" rat: relationship to the diabetic syndrome.

P Poussier, A F Nakhooda, J A Falk, C Lee, E B Marliss.   

Abstract

The "BB" rat spontaneously develops insulitis followed by impaired glucose tolerance (IGT) and/or an insulin-dependent diabetic syndrome like that in man. All diabetic rats in this study showed marked lymphopenia in blood, lymph nodes, spleen, and thymus. Peripheral blood lymphopenia antedated glucoregulatory disturbances. All rats showing either insulitis with or without IGT or diabetes were lymphopenic. None with normal lymphocyte counts developed any abnormality. Diabetics showed marked decrease in the proportions of T+ lymphocytes in all tissues. The proportion of B (Ia+) lymphocytes was normal in blood, spleen and thymus, but increased in lymph nodes. However, in absolute terms both T and Ia+ lymphocytes were decreased. The subset decreased by the greatest proportion in all tissues was that which includes helper T lymphocytes. Thus: a) generalized lymphopenia most marked for T lymphocytes has been shown, b) helper T lymphocytes show proportionally the greatest reduction, c)thymic helper T deficit suggests a thymic origin of the lymphopenia, d) lymphopenia is a possible marker for susceptibility to the syndrome.

Entities:  

Mesh:

Year:  1982        PMID: 6978807     DOI: 10.1210/endo-110-5-1825

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

1.  Elevated apoptosis of peripheral T lymphocytes in diabetic BB rats.

Authors:  C G Jung; T Kamiyama; T Agui
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Lactate production is the major metabolic fate of glucose in splenocytes and is altered in spontaneously diabetic BB rats.

Authors:  C J Field; G Wu; M D Métroz-Dayer; M Montambault; E B Marliss
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens.

Authors:  K S Sellins; D P Gold; D Bellgrau
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 4.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis.

Authors:  H Jaïdane; F Sané; R Hiar; A Goffard; J Gharbi; V Geenen; D Hober
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

5.  Spleen cell transfusion in the Bio-Breeding/Worcester rat. Prevention of diabetes, major histocompatibility complex restriction, and long-term persistence of transfused cells.

Authors:  A A Rossini; J P Mordes; D L Greiner; K Nakano; M C Appel; E S Handler
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

6.  Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.

Authors:  A A Like; V Dirodi; S Thomas; D L Guberski; A A Rossini
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

7.  Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat.

Authors:  T Dyrberg; P Poussier; F Nakhooda; E B Marliss; A Lernmark
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

8.  Changes in immune cell frequencies in primary and secondary lymphatic organs of LEW.1AR1-iddm rats, a model of human type 1 diabetes compared to other MHC congenic LEW inbred strains.

Authors:  Tanja Arndt; Anne Jörns; Dirk Wedekind
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

9.  Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat.

Authors:  A A Rossini; D Faustman; B A Woda; A A Like; I Szymanski; J P Mordes
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

10.  Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene.

Authors:  Armand J MacMurray; Daniel H Moralejo; Anne E Kwitek; Elizabeth A Rutledge; Brian Van Yserloo; Paul Gohlke; Sara J Speros; Ben Snyder; Jonathan Schaefer; Sabine Bieg; Jianjie Jiang; Ruth A Ettinger; Jessica Fuller; Terri L Daniels; Anna Pettersson; Kimberly Orlebeke; Bruce Birren; Howard J Jacob; Eric S Lander; Ake Lernmark
Journal:  Genome Res       Date:  2002-07       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.